Two courses of four weekly infusions of rituximab with or without interferon-α2a: final results from a randomized phase III study in symptomatic indolent B-cell lymphomas
| Image |  |
|---|---|
| Description | scientific article published on 17 February 2015 |
| Author/s |
author: Hans Hagberg Jan Delabie Björn E Wahlin Harald Holte |
| Publication date | February 17, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |